Cross-institution positioning
May 12, 2026Strong institutional reduction. 3 reducing, 2 exited across 5 comparable institutions.
Source: Schedule 13 researchSee how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Strong institutional reduction. 3 reducing, 2 exited across 5 comparable institutions.
Source: Schedule 13 research1 increased/new, 1 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 4 sales by 2 reporting owners. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/55 non-amendment material events in the last 90 days; 2 capital-related filing/events; Latest classified evidence: Other event. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +2.0% YoY; Net income +5.3% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 36% through its reported 52-week range; -7.7% over one year.
Source: Stored historical price seriesFiled May 12, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | Vincent George H. | FTax/price withholding or payment | Common Stock | 1.7K | $58.74 | Direct | Sep 28, 2026 |
| Sep 25, 2026 | Shaffer Megan N. | FTax/price withholding or payment | Common Stock | 269 | $58.74 | Direct | Sep 28, 2026 |
| Sep 25, 2026 | DEMARTINO EMILEE F. | AGrant, award, or other acquisition | Common Stock | 12.8K | $0.00 | Direct | Sep 28, 2026 |
| Sep 18, 2026 | Adcock Mary Ellen | MExercise or conversion of derivative · derivative | Non-Qualified Stock Options | 10.8K | $0.00 | Direct | Sep 21, 2026 |
| Sep 18, 2026 | Adcock Mary Ellen | MExercise or conversion of derivative · derivative | Non-Qualified Stock Options | 38.0K | $0.00 | Direct | Sep 21, 2026 |
| Sep 18, 2026 | Adcock Mary Ellen | SOpen-market or private sale | Common Stock | 24.1K | $60.68 | Direct | Sep 21, 2026 |
| Sep 18, 2026 | Adcock Mary Ellen | SOpen-market or private sale | Common Stock | 10.8K | $60.64 | Direct | Sep 21, 2026 |
| Sep 18, 2026 | Adcock Mary Ellen | SOpen-market or private sale | Common Stock | 38.0K | $60.74 | Direct | Sep 21, 2026 |
| Sep 18, 2026 | Adcock Mary Ellen | MExercise or conversion of derivative | Common Stock | 10.8K | $38.32 | Direct | Sep 21, 2026 |
| Sep 18, 2026 | Adcock Mary Ellen | MExercise or conversion of derivative | Common Stock | 38.0K | $34.94 | Direct | Sep 21, 2026 |
| Sep 1, 2026 | Aufreiter Nora A | AGrant, award, or other acquisition · derivative | Phantom Stock - Incentive Shares | 73 | $57.94 | Direct | Sep 2, 2026 |
| Sep 1, 2026 | Gates Anne | AGrant, award, or other acquisition · derivative | Phantom Stock - Incentive Shares | 188 | $57.94 | Direct | Sep 2, 2026 |
| Sep 1, 2026 | SARGENT RONALD | AGrant, award, or other acquisition · derivative | Phantom Stock - Incentive Shares | 462 | $57.94 | Direct | Sep 2, 2026 |
| Sep 1, 2026 | Sutton Mark S | AGrant, award, or other acquisition · derivative | Phantom Stock - Incentive Shares | 50 | $57.94 | Direct | Sep 2, 2026 |
| Jul 15, 2026 | FIKE CARIN L | FTax/price withholding or payment | Common Stock | 56 | $56.56 | Direct | Jul 16, 2026 |
| Jul 15, 2026 | Aufreiter Nora A | AGrant, award, or other acquisition | Common Stock | 3.7K | $0.00 | Direct | Jul 16, 2026 |
| Jul 15, 2026 | Brown Kevin M | AGrant, award, or other acquisition | Common Stock | 3.7K | $0.00 | Direct | Jul 16, 2026 |
| Jul 15, 2026 | Butier Mitchell R | AGrant, award, or other acquisition | Common Stock | 3.7K | $0.00 | Direct | Jul 16, 2026 |
| Jul 15, 2026 | Gates Anne | AGrant, award, or other acquisition · derivative | Phantom Stock - Incentive Shares | 3.7K | $0.00 | Direct | Jul 16, 2026 |
| Jul 15, 2026 | HOGUET KAREN M | AGrant, award, or other acquisition | Common Stock | 3.7K | $0.00 | Direct | Jul 16, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Oct 5, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Sep 29, 2026 | 424B5 | — | Prospectus filing | Capital-related | Filing |
| Sep 28, 2026 | 424B5 | — | Prospectus filing | Capital-related | Filing |
| Sep 11, 2026 | 8-K/AAmendment | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Sep 11, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Sep 2, 2026 | 8-K | 5.02, 7.01, 9.01 | Director or executive change; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jul 1, 2026 | 8-K | 8.01 | Other event | — | Filing |
| Jun 30, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| Jun 26, 2026 | 8-K | 5.02, 5.07, 9.01 | Director or executive change; Shareholder vote results; Financial statements / exhibits | — | Filing |
| Jun 18, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| May 27, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| Apr 21, 2026 | S-3ASR | — | Shelf securities registration | Capital-related | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Aug 15, 2026 | $34.6B | +2.0% |
| Ended Nov 8, 2025 | $33.9B | +0.7% |
| Ended Aug 16, 2025 | $33.9B | +0.1% |
| Ended Nov 9, 2024 | $33.6B | -1.0% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Jan 31, 2026 | $147.6B | +0.4% |
| Ended Feb 1, 2025 | $147.1B | -1.9% |
| Ended Feb 3, 2024 | $150.0B | +1.2% |
| Ended Jan 28, 2023 | $148.3B | +7.5% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 quarter end Aug 13, 2026 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 35.5M | $61.41 | |||
| State Street CIK0000093751 | Mar 31, 2026 observed May 12, 2026 filed · 42d Initial Schedule 13G | Initial Schedule 13G | 30.5M -1.5M | 12.00% 0.00 pts | $72.36 | $64.62 | $61.41 |
| Vanguard Capital Management CIK0002100119 | Mar 31, 2026 observed Apr 30, 2026 filed · 30d Initial Schedule 13G | Initial Schedule 13G | 42.4M | 6.90% | $72.36 | $68.07 | $61.41 |
Compare KR with other securities showing similar institutional activity or recent accumulation across several tracked institutions.